Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Raynaud phenomenon and scleroderma]

U F Haustein1

  • 1Klinik und Poliklinik für Hautkrankheiten der Universität, Leipzig.

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis.

Clinical pharmacology and therapeutics·2010
Same author

[Livedo racemosa with ulcerations. Cyclic therapy with iloprost infusions].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2007
Same author

[Centrifugal changing erythrosquamous plaque after a stay in West Africa].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2007
Same author

[Sports-induced infections--an overview].

Wiener medizinische Wochenschrift (1946)·2003
Same author

Death due to pulmonary tuberculosis in progressive systemic sclerosis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2002
Same author

Erosion of psoriatic plaques: an uncommon side-effect of neoadjuvant 5-fluorouracil treatment of colon cancer.

The British journal of dermatology·2002
Same journal

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral infections of the skin].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral exanthems in children].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Erratum to: Digital health applications and data protection].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Virus-induced exanthems in returning travellers].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Venous ulcus cruris-Surgical treatment].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
See all related articles

Raynaud phenomenon, common in systemic scleroderma, stems from vascular tone dysregulation. Novel vasodilatory treatments, like calcitonin gene-related peptide infusions, show promise for managing vasospasm.

Area of Science:

  • Rheumatology
  • Vascular Biology
  • Pharmacology

Background:

  • Raynaud phenomenon affects nearly all systemic scleroderma patients.
  • It arises from imbalanced vascular tone, involving vasoconstriction and vasodilation.
  • Endothelial damage and platelet activation trigger vasoactive substance release.

Purpose of the Study:

  • To explore the pathophysiology of Raynaud phenomenon in systemic scleroderma.
  • To investigate the role of vascular endothelium, platelets, and neural fibers in vasospasm.
  • To evaluate novel vasodilatory treatment strategies for systemic scleroderma-associated vasospasm.

Main Methods:

  • Review of existing literature on Raynaud phenomenon and systemic scleroderma.
  • Analysis of the mechanisms of vascular tone dysregulation.

Related Experiment Videos

  • Discussion of emerging therapeutic approaches, including peptide infusions.

    • Main Results:

    • Systemic scleroderma frequently presents with Raynaud phenomenon.
    • Vascular dysregulation involves endothelial dysfunction, platelet activation, and neural impairment.
    • Calcitonin gene-related peptides demonstrate potential as vasodilators.

    Conclusions:

    • Raynaud phenomenon is a hallmark of systemic scleroderma, driven by complex vascular mechanisms.
    • Targeting vasospasm with vasodilators like calcitonin gene-related peptides offers a promising therapeutic avenue.
    • Further research into these vasodilatory strategies is warranted for improved patient outcomes.